PMID- 37453994 OWN - NLM STAT- MEDLINE DCOM- 20230928 LR - 20230930 IS - 1559-1182 (Electronic) IS - 0893-7648 (Print) IS - 0893-7648 (Linking) VI - 60 IP - 11 DP - 2023 Nov TI - Improvement of Learning and Memory by Elevating Brain D-Aspartate in a Mouse Model of Fragile X Syndrome. PG - 6410-6423 LID - 10.1007/s12035-023-03438-0 [doi] AB - Fragile X syndrome (FXS) is an inherited human mental retardation that arises from expansion of a CGG repeat in the Fmr1 gene, causing loss of the fragile X mental retardation protein (FMRP). It is reported that N-methyl-D-aspartate receptor (NMDAR)-mediated facilitation of long-term potentiation (LTP) and fear memory are impaired in Fmr1 knockout (KO) mice. In this study, biological, pharmacological, and electrophysiological techniques were performed to determine the roles of D-aspartate (D-Asp), a modulator of NMDAR, and its metabolizing enzyme D-aspartate oxidase (DDO) in Fmr1 KO mice. Levels of D-Asp were decreased in the medial prefrontal cortex (mPFC ); however, the levels of its metabolizing enzyme DDO were increased. Electrophysiological recordings indicated that oral drinking of D-Asp recovered LTP induction in mPFC from Fmr1 KO mice. Moreover, chronic oral administration of D-Asp reversed behavioral deficits of cognition and locomotor coordination in Fmr1 KO mice. The therapeutic action of D-Asp was partially through regulating functions of NMDARs and mGluR5/mTOR/4E-BP signaling pathways. In conclusion, supplement of D-Asp may benefit for synaptic plasticity and behaviors in Fmr1 KO mice and offer a potential therapeutic strategy for FXS. CI - (c) 2023. The Author(s). FAU - Li, Yu-Jiao AU - Li YJ AD - Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, China. AD - Department of Pharmacy, General Hospital of Eastern Theater Command/Jinling Hospital, Medical School of Nanjing University, Nanjing, 210002, China. FAU - Zhang, Kun AU - Zhang K AD - Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, China. FAU - Sun, Ting AU - Sun T AD - Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, China. FAU - Guo, Yan-Yan AU - Guo YY AD - Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, China. FAU - Yang, Qi AU - Yang Q AD - Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, China. FAU - Liu, Shui-Bing AU - Liu SB AD - Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, China. FAU - Wu, Yu-Mei AU - Wu YM AD - Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, 710032, Shaanxi Province, China. yumeiwu@fmmu.edu.cn. FAU - Zhao, Ming-Gao AU - Zhao MG AUID- ORCID: 0000-0002-7539-3887 AD - Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, Shaanxi Province, China. minggao@fmmu.edu.cn. LA - eng GR - 31972902/National Natural Science Foundation of China/ GR - 32241007/National Natural Science Foundation of China/ GR - 82221001/National Natural Science Foundation of China/ GR - 82071515/National Natural Science Foundation of China/ PT - Journal Article DEP - 20230715 PL - United States TA - Mol Neurobiol JT - Molecular neurobiology JID - 8900963 RN - 4SR0Q8YD1X (D-Aspartic Acid) RN - 139135-51-6 (Fragile X Mental Retardation Protein) RN - 0 (Fmr1 protein, mouse) SB - IM MH - Mice MH - Animals MH - Humans MH - *D-Aspartic Acid MH - *Fragile X Syndrome/drug therapy/metabolism MH - Learning MH - Long-Term Potentiation/physiology MH - Fragile X Mental Retardation Protein/metabolism MH - Mice, Knockout MH - Brain/metabolism MH - Disease Models, Animal MH - Mice, Inbred C57BL PMC - PMC10533629 OTO - NOTNLM OT - D-Aspartate OT - Fear memory OT - Fragile X syndrome OT - Long-term potentiation OT - mGluR5 COIS- The authors declare no competing interests. EDAT- 2023/07/16 01:06 MHDA- 2023/09/28 06:42 PMCR- 2023/07/15 CRDT- 2023/07/15 23:05 PHST- 2023/03/19 00:00 [received] PHST- 2023/06/10 00:00 [accepted] PHST- 2023/09/28 06:42 [medline] PHST- 2023/07/16 01:06 [pubmed] PHST- 2023/07/15 23:05 [entrez] PHST- 2023/07/15 00:00 [pmc-release] AID - 10.1007/s12035-023-03438-0 [pii] AID - 3438 [pii] AID - 10.1007/s12035-023-03438-0 [doi] PST - ppublish SO - Mol Neurobiol. 2023 Nov;60(11):6410-6423. doi: 10.1007/s12035-023-03438-0. Epub 2023 Jul 15.